# EDGAR Filing Document

**Accession Number:** 0002007702
**File Stem:** 0001213900-26-040523
**Filing Date:** 2026-4
**Character Count:** 2294
**Document Hash:** 993a724b9a95c1568a89df1b475d762e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-040523.hdr.sgml**: 20260506

**ACCESSION NUMBER**: 0001213900-26-040523

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260406

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Cellyan Biotechnology Co., Ltd
- **CENTRAL INDEX KEY:** 0002007702
- **STANDARD INDUSTRIAL CLASSIFICATION:** WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** ROOM B1, 5/F. WELL TOWN IND. BUILDING
- **STREET 2:** 13 KO FAI ROAD, YAU TONG
- **CITY:** KOWLOON
- **PROVINCE COUNTRY:** K3
- **BUSINESS PHONE:** (852) 26189289

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** ROOM B1, 5/F. WELL TOWN IND. BUILDING
- **STREET 2:** 13 KO FAI ROAD, YAU TONG
- **CITY:** KOWLOON
- **PROVINCE COUNTRY:** K3

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Hong Kong Pharma Digital Technology Holdings Ltd
- **DATE OF NAME CHANGE:** 20240110

**CELLYAN BIOTECHNOLOGY CO., LTD**

**Room B1, 5/F., Well Town Industrial Building, 13 Ko Fai Road, Yau Tong, Kowloon**

**Hong Kong**

**+852 2618-9289**

April 6, 2026

**<u>VIA EDGAR</u>**

U.S. Securities & Exchange Commission

Division of Corporation Finance

Office of Trade & Services

100 F Street, NE

Washington, D.C. 20549

Attn: Kate Beukenkamp

---

| | |
|:---|:---|
| **Re:** | **Cellyan Biotechnology Co., Ltd** |
|  | **Registration Statement on Form F-1** |
|  | **Filed March 27, 2026** |
|  | **File No. 333-294685** |

---

Dear Ms. Beukenkamp:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Cellyan Biotechnology Co., Ltd hereby requests acceleration of effectiveness of the above referenced Registration Statement on Form F-1 (File No. 333-294685) so that it will become effective at 5:00 p.m. ET on Wednesday, April 8, 2026, or as soon as thereafter practicable.

---

| |
|:---|
| Very truly yours, |
| /s/ Chenyu Liang |
| Chenyu Liang |
| Chief Executive Officer and Director |

---

cc: McLaughlin & Stern, LLP